Literature DB >> 29462242

Gonadotropins and their receptors: coevolution, genetic variants, receptor imaging, and functional antagonists.

Aaron J Hsueh1, Jiahuan He1.   

Abstract

Gonadotropins belong to the family of dimeric glycoprotein hormones and regulate gonadal physiology mediated by G protein-coupled, seven-transmembrane receptors. These glycoprotein hormones are widely used in the clinic to promote ovarian follicle development and for treating some cases of male infertility. We traced the coevolution of dimeric gonadotropin hormones and their receptors, together with thyrotropin and its receptor. We updated recent findings on human genetic variants of these genes and their association with dizygotic twining, polycystic ovarian syndrome, primary ovarian insufficiency, male-limited precocious puberty, and infertility. In addition to the known physiological roles of gonadotropin-receptor signaling in gonadal tissues, we also discussed emerging understanding of extragonadal functions of gonadotropins in bones and adipose tissues, together with recent advances in in vivo imaging of gonadotropin receptors in live animals. Recent development of gonadotropin receptor agonists and antagonists were summarized with an emphasis on the development of functional antagonists for FSH receptors to alleviate osteoporosis and obesity associated with menopause.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29462242     DOI: 10.1093/biolre/ioy012

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  2 in total

Review 1.  Hormone supply to the pituitary gland: A comprehensive investigation of female‑related tumors (Review).

Authors:  Wenxiu Tian; Huimin Qi; Zhimei Wang; Sen Qiao; Ping Wang; Junhong Dong; Hongmei Wang
Journal:  Int J Mol Med       Date:  2022-08-10       Impact factor: 5.314

2.  A Novel Follitropin Analog Inhibits Follitropin Activity In Vitro.

Authors:  Naiel Azzam; Rinat Bar-Shalom; Fuad Fares
Journal:  Pharmaceutics       Date:  2021-03-03       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.